"Hyperandrogenism" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition caused by the excessive secretion of ANDROGENS from the ADRENAL CORTEX; the OVARIES; or the TESTES. The clinical significance in males is negligible. In women, the common manifestations are HIRSUTISM and VIRILISM as seen in patients with POLYCYSTIC OVARY SYNDROME and ADRENOCORTICAL HYPERFUNCTION.
| Descriptor ID |
D017588
|
| MeSH Number(s) |
C12.706.316.064.500 C12.706.316.129.750 C13.351.875.253.064.500 C13.351.875.253.129.750 C16.131.939.316.064.500 C16.131.939.316.129.750 C19.391.119.064.500 C19.391.119.129.750
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hyperandrogenism".
Below are MeSH descriptors whose meaning is more specific than "Hyperandrogenism".
This graph shows the total number of publications written about "Hyperandrogenism" by people in this website by year, and whether "Hyperandrogenism" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 1 | 2 |
| 2002 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2011 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hyperandrogenism" by people in Profiles.
-
Associations between vitamin D levels and polycystic ovary syndrome phenotypes. Minerva Endocrinol. 2019 Jun; 44(2):176-184.
-
Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype. Am J Obstet Gynecol. 2017 05; 216(5):493.e1-493.e13.
-
Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011 Mar 01; 95(3):1073-9.e1-11.
-
13-cis-Retinoic acid (isotretinoin) unmasking of clinical polycystic ovary syndrome. Endocr Pract. 2007 Nov-Dec; 13(7):776-9.
-
Prevalence of CYP21 mutations and IRS1 variant among women with polycystic ovary syndrome and adrenal androgen excess. Fertil Steril. 2005 Feb; 83(2):371-5.
-
Increased frequency of the G972R variant of the insulin receptor substrate-1 (irs-1) gene among girls with a history of precocious pubarche. Fertil Steril. 2002 Dec; 78(6):1288-93.
-
Inconsistent effects of the proline12 --> alanine variant of the peroxisome proliferator-activated receptor-gamma2 gene on body mass index in children and adolescent girls. Fertil Steril. 2001 Oct; 76(4):741-7.
-
Candidate gene analysis in premature pubarche and adolescent hyperandrogenism. Fertil Steril. 2001 Apr; 75(4):724-30.
-
The role of heterozygosity for CYP21 in the polycystic ovary syndrome. J Pediatr Endocrinol Metab. 2000; 13 Suppl 5:1315-7.